Article
Clinical utility of kallikrein-related peptidases (KLK) in urogenital malignancies.
Thrombosis and haemostasis - 1 Sept 2013
Dorn J, Bayani J, Yousef G M, Yang F, Magdolen V, Kiechle M, Diamandis E P, Schmitt M
Abstract excerpt
Kallikrein-related peptidases (KLK), which represent a major tissue-associated proteolytic system, stand for a rich source of biomarkers that may allow molecular classification, early diagnosis and prognosis of human malignancies as well as prediction of response or failure to cancer-directed drugs. International research points to an important role of certain KLKs in female and male urogenital tract...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
